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Abstract
Desmoglein-3 (Dsg3), the Pemphigus Vulgaris (PV) antigen (PVA), plays an essential role in keratinocyte cell–cell
adhesion and regulates various signaling pathways involved in the progression and metastasis of cancer where it is
upregulated. We show here that expression of Dsg3 impacts on the expression and function of p53, a key transcription
factor governing the responses to cellular stress. Dsg3 depletion increased p53 expression and activity, an effect
enhanced by treating cells with UVB, mechanical stress and genotoxic drugs, whilst increased Dsg3 expression
resulted in the opposite effects. Such a pathway in the negative regulation of p53 by Dsg3 was Dsg3 specific since
neither E-cadherin nor desmoplakin knockdown caused similar effects. Analysis of Dsg3−/− mouse skin also indicated
an increase of p53/p21WAF1/CIP1 and cleaved caspase-3 relative to Dsg3+/− controls. Finally, we evaluated whether this
pathway was operational in the autoimmune disease PV in which Dsg3 serves as a major antigen involved in blistering
pathogenesis. We uncovered increased p53 with diffuse cytoplasmic and/or nuclear staining in the oral mucosa of
patients, including cells surrounding blisters and the pre-lesional regions. This finding was verified by in vitro studies
where treatment of keratinocytes with PV sera, as well as a characterized pathogenic antibody specifically targeting
Dsg3, evoked pronounced p53 expression and activity accompanied by disruption of cell–cell adhesion. Collectively,
our findings suggest a novel role for Dsg3 as an anti-stress protein, via suppression of p53 function, and this pathway is
disrupted in PV.
Introduction
Desmoglein-3 (Dsg3), a cadherin superfamily member,
is an adhesion protein in desmosomes. Recent evidence
suggests that Dsg3 acts as a regulator of various pathways
governing cell adhesion, proliferation, differentiation,
morphogenesis, and migration1–7. However, the function
of non-junctional Dsg3 remains poorly understood. In the
skin, Dsg3 is largely restricted to the basal layer of the
epidermis, while in oral mucosa uniform expression
occurs across stratified squamous epithelia8,9. Why these
different distribution patterns exist is unknown.
Dsg3 is down-regulated in PV where Dsg3 serves as a
major antigen (PVA) for autoantibodies, causing disrup-
tion of cell–cell cohesion and pemphigus acantholysis in
Dsg3-expressing tissues10–14. However, other studies
suggest PV is caused by autoantibodies that target non-
Dsg receptors, triggering intracellular signaling and con-
sequently cell apoptosis, leading to blistering14–16. Despite
numerous studies, the pathogenesis of PV remains an
issue of debate15,17.
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Dsg3 is upregulated in cancer with its exact role remains
uncertain1. In vitro gain-of-function experiments support
its pro-cancerous role; overexpression of Dsg3 elicited
pronounced membrane protrusions and augmented cell
migration via activation of various pathways1,3–5,18. Con-
versely, Dsg3 depletion resulted in inhibition of tumor
growth and metastasis19.
Our preliminary observation, made in MDCK
(Madin–Darby canine kidney) cells, showed that dome
formation, marking the initiation of epithelial cell dif-
ferentiation20–22 was suppressed by Dsg3 overexpression.
Furthermore, overexpression of Dsg3 resulted in the
suppression of p53/p21WAF1/CIP1, suggesting that Dsg3
could act as an anti-stress protein through negative
regulation of p5323. p53 is found to be upregulated in
some epidermal pathologies, such as psoriasis24,25 and
lichen planus (LP)26–28, though whether any alteration of
p53 in PV currently remains unknown. Here, we inves-
tigate the hypothesis that Dsg3 counteracts p53 in ker-
atinocytes and explore its potential contribution to the
pathogenesis of PV.
Results
Dsg3 depletion induces p53 in keratinocytes
To investigate our hypothesis, we performed an RNAi
study in NTERT keratinocytes harboring wild type p53
(wtp53). Knockdown of Dsg3 caused no apparent changes
in other junctional proteins including Dsg2 (not shown).
Immunofluorescence indicated a significant induction of
nuclear p53 in cells with Dsg3 knockdown compared to
controls (Fig. 1a). Western blotting detected only a
moderate but significant increase of p53 with an increase
of its targets p21WAF1/CIP1/Bax (Fig. 1b). Lysates of the
nuclear and cytoplasmic fractions of the siRNA treated
cells were extracted and subjected to Western blotting
analysis. Increased p53/p21WAF1/CIP1 was evident in the
nuclear fraction of RNAi treated cells relative to control
(Fig. 1c), confirming augmented p53 levels in cells with
Dsg3 depletion. To determine the specificity of Dsg3
RNAi mediated p53 induction, we performed double
knockdown for Dsg3/p53 that demonstrated the induc-
tion of p53 is mediated by Dsg3 depletion since cells with
double knockdown showed attenuation of enhanced
p21WAF1/CIP1 expression (Fig. 1d). In parallel, we per-
formed Dsg3 knockdown in NTERTs with the lentiviral
shRNAs (Dharmacon, USA) targeting three different
regions in the Dsg3 gene. We found that one hit rendered
Dsg3 knockdown coupled with induction of p53/
p21WAF1/CIP1 relative to non-target control whereas the
other two hits evoked no Dsg3 knockdown and sig-
nificantly no p53 induction (Fig. 1e). In line with these
data, immunofluorescence also detected a significant
increase of p53 in both nucleus and cytoplasm in
knockdown cells compared to controls (Hit-1 in Fig. 1f).
To further evaluate the specificity of the Dsg3-p53 path-
way, we performed similar knockdown experiments for
desmoplakin, a marker of desmosomes and E-cadherin, a
classical cadherin in adherens junctions and found that
neither desmoplakin nor E-cadherin depletion evoked
comparable effects (Fig. 1g, h, see below).
Because of the highly dynamic nature of p5329, we were
concerned that moderate changes in p53 in knockdown
cells might be masked partially by its rapid turnover.
Hence, we treated the siRNA transfected cells with MG-
132 (25 µM, 3 h) before protein extraction and a greater
increase of both p53 and p21WAF1/CIP1 was detected in
Dsg3 knockdown cells (Fig. 2a). Similar results were
observed in lentivirus shRNA Hit-1 cells compared to
controls (Fig. 1e). We also monitored p53 protein turn-
over in cells treated with cycloheximide (30 µg/ml) by
extracting protein at various time points for up to 6 h. As
expected, a delayed reduction of p53, accompanied by
stabilization of MDM2, a key negative regulator of p5330,
was found in Dsg3-depleted cells compared to controls
(Fig. 2b). p53 half-life calculations indicated the protein
existed approximately 2-fold longer in knockdown cells
than in control cells (~120min in RNAi vs ~50min in
control). To test whether the regulation of p53 by Dsg3
had functional consequences we monitored whether there
was an increased expression of cleaved/active caspase-3,
an established specific marker of epithelial apoptosis31. A
FACS based Zombie NIR-caspase-3 assay32 was per-
formed in siRNA pre-treated cells grown to confluent and
sub-confluent conditions that detected a marked increase
of positive caspase-3 events (Zombie NIR−ve/Caspase-
3+ve) in Dsg3 knockdown cells as compared to the
respective controls; the effects were seen particularly in
sub-confluent culture (Fig. 2c). Furthermore, we also
detected a reduction of PCNA and Cyclin A that regulate
cell cycle progression, in cells with Dsg3 knockdown (see
below in Fig. 3d). Collectively, these findings are con-
sistent with our hypothesis that Dsg3 restrains p53
expression and activity.
Dsg3 overexpression causes suppression of p53 and
activity
To confirm our findings, an alternative approach with
gain-of-function was conducted in a cutaneous cell line
T8 (p53 null) expressing low endogenous Dsg3. T8 cells
with transduction of pBABE-hDsg3.myc to overexpress
Dsg3 (D3) or pBABE-puro empty vector (Vect), were
transiently transfected with a wtp53 plasmid for 2d prior
to analysis of p53 expression. We observed marked sup-
pression of p53/p21WAF1/CIP1 in D3 line, compared to
Vect control, at both the transcript and protein levels (Fig.
2d, e). The p53 transcriptional activity was confirmed by a
p53 luciferase assay (Fig. 2f). These results, again, support
our hypothesis that Dsg3 negatively regulates p53. To
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explore the broad role of p53 in cell biology, the influence
of Dsg3 modulation (knockdown and ectopic over-
expression) on the keratinocyte differentiation program
was examined by a series of qPCR analyses for various
genes involved in early and late differentiation programs
in keratinocytes. To this end, we observed a general
inverse relationship between Dsg3 expression and key
keratinocyte differentiation markers (Fig. S1). Thus,
Dsg3 silencing caused their enhanced expression [pre-
mature cell differentiation] whereas the inverse result was
detected in Dsg3 overexpressing cells (cell dedifferentia-
tion). These results suggest that the Dsg3-p53 pathway
has some influence, at least in part, on the keratinocyte
differentiation program.
Dsg3 constrains p53 in response to stress
Dsg3 expressing tissues, e.g. skin and oral mucosa, are
exposed daily to various stresses that could induce p5323.
Thus, we challenged cells with various stresses, i.e. UV
exposure and mechanical stretching, before analyzing p53.
Cells subjected to UVB irradiation (10–30mJ/cm2)
showed a trend of elevated p53/p21WAF1/CIP1 after 1d.
This effect was enhanced markedly in Dsg3 depleted cells,
indicating Dsg3’s ability to antagonize UV induced p53
expression (Figs. 1e, 3a). Reduction in cell cycle regulators
PCNA and Cyclin A was demonstrated by Western
blotting analysis in knockdown cells in both the presence
and absence of UV (Fig. 3d). Moreover, Bax immunos-
taining indicated enhanced signals in both the cyto-
plasmic and nuclear compartments in RNAi treated cells
(Fig. S4a). Consistently, overexpression of Dsg3 resulted
in suppression of p53/p21WAF1/CIP1 after UV (Fig. S2a).
Moreover, these cells were highly resistant to UV-induced
cell death relative to control cells. Similar findings were
made in A2780 and HCT116 (wtp53) (Fig. S2b). Addi-
tionally, cells treated with genotoxic drugs, such as acti-
nomycin D (Act D) or mitomycin C (MMC), also showed
a similar effect with strong induction of p53/p21WAF1/CIP1
in Dsg3 depleted cells compared to cells without knock-
down (Fig. 3b). These data suggest that the expression of
Dsg3 protects cells against various environmental insults
by dampening the p53 response. This hypothesis was
supported by additional mechanical loading experiments
in which siRNA treated cells were challenged with
equiaxial cyclic strain (FX-5000: 1 Hz, 20%) for 4 h.
Lysates extracted either immediately after strain (0 h) or 2
and 24 h later, respectively, followed by Western blotting
analysis. It showed increased p53/p21WAF1/CIP1/Bax in
Dsg3 knockdown cells, particularly at 0 h and 2 h in post-
strained cells (Fig. 3c). Thus the loss of Dsg3 affected
p53 stabilization in response to mechanical stress rein-
forcing its ability to counterbalance p53 response to
mechanical stress.
To explore the upstream components involved in p53
activation in our knockdown system, we analyzed total
and phosphorylated protein expression of ATM serine/
threonine protein kinase, as well as one of its targets
CHK2, which is activated by DNA double-strand breaks33.
Cells were subjected to UV or no UV exposure for 1 day
before Western blotting analysis (Fig. 3e). Although the
effects were modest both phospho-ATM (pATM) and
-CHK2 (pCHK2) showed elevated levels as well as total
p53/phospho-p53-S20 in Dsg3 depleted cells, with further
enhancement by UVB. Both total proteins also showed a
similar expression pattern with increased levels in
knockdown cells compared to controls, regardless of UV.
These results suggest that the DNA double-strand break
induced activation of pATM is involved in the upregula-
tion of the p53 pathway in Dsg3 depleted cells. To con-
firm the presence of DNA double-strand breaks in these
cells we performed immunofluorescence for 53BP1 and
measured the nuclear foci in both control and Dsg3
depleted cells with and without UVB. Increased number
of 53BP1 foci indicated enhanced DNA double-strand
breaks, in particular in Dsg3 depleted cells exposed to
UVB which were significantly different from scrambled
siRNA controls (Fig. 3f). Finally, cells were treated in the
presence and absence of KU55933 (ATM inhibitor) and
SB203580 (p38 MAPK inhibitor) and both drugs inhib-
ited the enhanced CHK2 phosphorylation in Dsg3
depleted cells relative to corresponding scrambled
siRNA controls in parallel with a strong reduction in
(see figure on previous page)
Fig. 1 Dsg3 depletion in human keratinocytes enhances p53 expression and activity. a Immunofluorescence in NTERTs transiently transfected
with Dsg3 specific or scrambled siRNA for 2d showed significantly increased nuclear p53 relative to control (n= 7, pooled from 2 independent
experiments). Scale bars, 20 µm. b Western blotting for p53 and its targets, p21WAF1/CIP1/Bax, in NTERTs with Dsg3 knockdown indicated a moderate
but significant increase of p53 (n= 3–4). c Biochemical fractionation of NTERTs with or without Dsg3 knockdown (RNAi). Increased p53 and p21WAF1/CIP1
in RNAi samples, especially in the nuclear fraction compared to control. d Western blots for the indicated antibodies in lysates with single (Dsg3) and
double (Dsg3/p53) knockdown. e Western blotting analysis of NTERT cell lines with transduction of GIPZ Lentiviral shRNAs, including non-target (NT)
and three hits targeting different regions in the Dsg3 gene. Cells with transduction of one (Hit-1), among three hits, exhibited Dsg3 knockdown with
concomitant induction of p53/ p21WAF1/CIP1 without and with either MG-132 (25 µM for 3 h) or UVB irradiation, as compared to NT and negative Hit
controls. f Immunofluorescence analysis indicated a marked increase of p53 in both the nucleus and cytoplasm in cells with transduction of Hit-1
compared to NT and other negative Hit controls. g, h Western blotting analysis in NTERTs with Dp or E-cadherin knockdown shows distinct protein
expression profiles for p53/p21WAF1/CIP1/Bax. Cells treated without and with UVB irradiation were shown here (see Dsg3 KD+ UV in Fig. 3a below).
(mean ± s.d., *p < 0.05, **p < 0.01, ***p < 0.001)
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Fig. 2 The p53 suppression by Dsg3 was further supported by the inhibition of protein degradation and overexpression of Dsg3. aWestern
blots of siRNA-transfected cells with and without treatment of MG-132 (25 µM) for 3 h. GAPDH and HSC70 were the loading controls. b Protein turnover
analysis for p53, as well as MDM2, indicated reduced p53 turnover accompanied by MDM2 stabilization in Dsg3 depleted cells. The above is the timeline
of the experiment. The band density for each blot was normalized against the loading control in each sample and then against the one at 0min time
point in each condition. The calculated half-life for p53 and MDM2 were shown in the graphs. c Flow cytometric analysis of cell viability with live cells
(Zombie NIR−ve/Caspase-3−ve), Zombie NIR−ve/Caspase-3+ve, both positive (Zombie NIR+ve/Caspase-3+ve) and Zombie NIR+ve/Caspase-3−ve in NTERTs
with and without Dsg3 knockdown, grown at 100% or ~40% confluences (the represented data of 3 independent attempts). d Protein expression in
cutaneous keratinocytes T8 (p53 null, with p53 transfection) Vect control and Dsg3 overexpression (D3) that showed suppression of p53/p21WAF1/CIP1 in
D3 cells compared to Vect cells. e RT-qPCR analysis of p53 expression (mean ± s.e.m.) in T8 cell lines (n= 3 independent assays of duplicate in each test).
f p53 luciferase assay (mean ± s.d.) in T8 cell lines (n= 3, a representative of two independent experiments). The comparison was via unpaired two-sided
student t-test. (**p < 0.01, **p < 0.01, ***p < 0.001)
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total p53/phospho-p53-S20 (Fig. 3g, h) and this was
particularly marked in the case of SB203580 (Fig. 3h
right panel). These findings suggest that, in the presence
of DNA damage, Dsg3 depletion further potentiates
DNA double-strand breaks, which are involved in acti-
vation of ATM and its downstream targets CHK2 and
p53, leading to cell cycle arrest and pre-apoptosis.
Again, the knockdown studies for desmoplakin and E-
cadherin were performed in conjunction with UV but no
comparable results were obtained, albeit the UV exposure
induced p53 (Fig. 1g, h). Only a small reduction of p53/
p21WAF1/CIP1/Bax was detected in E-cadherin knockdown.
No apparent changes of p53 were shown in desmoplakin
knockdown while it had no effect on p21WAF1/CIP1 and
only caused a marginal increase in Bax. Collectively, these
data suggest that the regulation of p53 by Dsg3 likely is
independent of desmoplakin and E-cadherin, implying
that this pathway may be mediated by extra-desmosomal
Dsg317.
Increased p53 expression and activity in Dsg3−/− mouse
skin in vivo
Having confirmed that Dsg3 negatively regulates p53 in
keratinocytes, we then asked whether alteration of this
pathway is detectable in Dsg3 knockout mice. Mice with
targeted ablation of Dsg3 exhibit runting and wave-pattern
hair loss, accompanied by oral and skin lesions, after
weaning34,35. Increased expression of p53/p21WAF1/CIP1/
cleaved caspase-3 was detected in Dsg3−/− hair follicles in
dorsal skin samples from such mice, but not in Dsg3+/−
littermates (Fig. 4). This result confirmed that Dsg3
expression is associated with the prevention of p53 acti-
vation in mouse skin in vivo.
Enhanced p53 expression in PV and in keratinocyte
cultures treated with PV sera as well as a characterized
pathogenic antibody
To explore whether our identified pathway is operative
in PV, we performed immunohistochemistry for p53 in
oral tissue biopsies from 25 patients and found a
remarkable increase of p53, in both cytoplasm and
nucleus across almost the entire stratified epithelial layer,
in 12 PV cases (~50%), especially in cells surrounding or
in the clusters within blisters. Normal samples showed
only a few p53 nuclear-positive cells located in the basal
and suprabasal layers (Fig. 5a). Cells immunopositive for
cleaved caspase-3 in PV were also positive for p53, indi-
cating activation of the p53 pathway in PV (Fig. 5b).
Notably, positive staining for both proteins was observed
in non-lesional areas in PV (Case-3 in Fig. 5). These
results are indicative of alterations of the Dsg3-p53
pathway in PV that lead to caspase-3 activation as
reported previously36.
Since activation of p53 occurs in other diseases as
described above, it is important to determine the speci-
ficity of this Dsg3-p53 pathway in PV. To evaluate our
in vivo finding in PV, next, in vitro studies were per-
formed with PV sera collected from a different cohort of
17 patients, and more specifically, with AK23, a well-
characterized pathogenic monoclonal antibody targeting
the adhesion site at Dsg3 N-terminus37. Confluent cells
were treated with PV sera or AK23 (40% PV sera,
1–100 µg/ml AK23) before immunostaining for p53/Dsg3
(Fig. 6a–e). In controls treated with normal sera, nuclear
p53 was predominant, with limited cytoplasmic staining.
In contrast, cells treated with PV sera (for 24 h) exhibited
an augmentation of both nuclear and cytoplasmic p53
(Fig. 6a–c). In some samples, membranous and cyto-
plasmic staining was evident. Intriguingly, the membrane
distribution of p53 showed co-localization with Dsg3
where there was severe membrane disruption (Fig. 6a
arrows in the inserts). The enhanced cytoplasmic p53 in
PV serum-treated cells may indicate the enhanced protein
synthesis (Fig. 6c). In parallel, treatment with AK23 mir-
rored increased nuclear p53, in a time and dose-
dependent manner (Fig. 6d, e). As expected, disruption
of junctions was apparent in cells with membrane dis-
tribution of p53 (arrows in Fig. 6e). Some difference in
(see figure on previous page)
Fig. 3 Dsg3 depletion causes further induction of p53 expression and activity in response to stress signals. a Western blotting of siRNA pre-
treated NTERT cells with and without UVB irradiation for the indicated proteins with the quantitation shown on the right (n= 3 biologically independent
samples, *p < 0.05). bWestern blotting for p53/p21WAF1/CIP1 in cells treated with or without actinomycin D (Act D, 5 nM) and mitomycin C (MMC, 5 µg/ml)
for 24 h, respectively. The quantitation data are shown on the right. Enhanced expression of p53/p21WAF1/CIP1 was shown in cells with Dsg3 knockdown
and treated with drugs. c Mechanical stretching induced increased expression of p53 and p21WAF1/CIP1/ Bax in Dsg3 KD cells. The siRNA pre-treated cells
were seeded at confluent density in BioFlex plates and then subjected to cyclic strain (TX-5000, 20% amplitude, 1 Hz) for 4 h the following day. Lysates
were extracted either immediately after strain or 2 h and 24 h later, respectively, after transferring to a stationary state, along with static control cells.
d Western blotting analysis for PCNA and cyclin A in siRNA treated cells with and without UV. e Western blots for the indicated proteins upstream of p53
as well as phospho-p53-S20 in siRNA pre-treated cells with and without UVB (30mJ/cm2). f Qnatitation of 53BP1 nuclear staining (n= 10, mean ± S.D.,
**p < 0.01, ***p < 0.001). g Western blotting in siRNA transfected cells treated in the presence and absence of ATM inhibitor KU55933 (20 µM) and p38
MAPK inhibitor SB203580 (20 µM), respectively. All cells were exposed to UVB (30mJ/cm2) in this case. Cells were treated with drugs 1 h before UV and
were grown overnight before lysate extraction. h The expression of p53 in the same samples as phosphorylated ATM and CHK2 (the last two corrected for
total protein) following the indicated drug treatments in Dsg3-depleted cells. The data are expressed as the band intensities in the Dsg3-depleted cells
relative to the corresponding scrambled siRNA controls, which were normalized to 1
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p53 staining was observed between AK23 and PV serum-
treated cells suggesting variations between monoclonal
antibody and patient sera with polyclonal antibodies. The
specificity of enhanced p53, induced by PV sera, was
confirmed by p53 knockdown experiments where cells
were transfected with p53 siRNA alongside with control
siRNA for 1d before treated with PV or control sera. p53
knockdown almost completely abolished p53 signals in
control of serum-treated cells (Fig. S3). However, in the
PV serum treated samples, although some non-specific
background in p53 staining was shown in cases, p53
knockdown rendered significant reduction of p53 (Fig. 6a
right panel, Figure S3). Additionally, Bax staining showed
enhanced cytoplasmic signals in cells treated with PV sera
(Fig. S4b). For Dsg3 staining, two Dsg3 antibodies were
used. While Dsg3 staining with rabbit antibody (H145)
that binds to its C-terminus exhibited broad variations,
another mouse antibody (5H10) that binds the N-
terminus at the extracellular domain of Dsg3 showed
marked depletion of Dsg3 from the surface in cells treated
with PV sera (Fig. 6a, b). Drastic disruption/reduction of
Dsg3 at the junctions was detected with H145 in cells
treated with PV sera and to a lesser extent, with AK23
(arrowhead in Fig. 6a, e). Some PV sera samples even
showed a marked increase accompanied with pronounced
Dsg3 disruption at the junctions and its aggregates in the
cytoplasm (PV serum-12, Fig. 6a). Taken together, these
in vitro findings demonstrate that treatment of keratino-
cytes with PV autoantibodies and pathogenic antibody
evoked marked disruption/depletion of Dsg3 from the
plasma membrane, leading to induction of p53 and
activation.
Discussion
p53, a “guardian of the genome”, is a central player in
cell responses to environmental stress23,29. Here we pro-
vide the first evidence that Dsg3 acts as an anti-stress
protein by restricting p53 responses to stress signals in
keratinocytes (Fig. 6f). Knockdown of Dsg3 in vitro or its
ablation in vivo caused elevated expression/stabilization
of p53, coupled with decreased PCNA and Cyclin A, and
increased activation of caspase-3, indicative of early
apoptosis31,36. Our in vitro studies suggest an involvement
of at least ATM and CHK2 activation upstream of p53
upregulation, following Dsg3 depletion. This effect was
more pronounced in cells exposed to various stresses.
Conversely, overexpression of Dsg3 resulted in the
opposite effect with marked suppression of p53. Finally,
we showed that this pathway seemed to be altered in PV,
at least in a subset of patients, suggesting that the anti-
bodies which mediated Dsg3 disruption induces p53
activation. This finding underscores the possibility that
failure in this anti-stress pathway contributes to PV
acantholysis.
PV is caused by autoantibodies targeting Dsgs that lead
to defects in cell–cell adhesion, however, the precise
molecular mechanism is still not fully understood. Pre-
vious studies indicated that apoptosis and activation of
caspases are involved in PV pathogenesis with the hypoth-
esis that an activated death signaling could be the under-
lying mechanism in PV-IgG induced acantholysis38–41.
Increased FasL/FasR were detected in keratinocyte and skin
organ cultures treated with PV-IgG39–41. In addition, there
is evidence suggesting that blistering is associated with
Fig. 4 Increased expression of p53, p21WAF1/CIP1 and cleaved
caspase-3 is observed in the back skin of Dsg3 knockout mice.
a Immunofluorescent staining in the back skin of Dsg3−/− and Dsg3+/−
(heterozygous littermate) mice showed elevated signals for the
indicated proteins in the hair follicles of Dsg3−/− mice compared to
heterozygous littermate, though no positive staining was observed in
the epidermis (n= 2 mice per group, aged 8–12 weeks). Some
fibroblasts in the dermis were also shown positive staining of p53. Epi:
epidermis, HF: hair follicle. The inset in the top right panel highlight
cells with double positive staining for p53 and active caspase-3 in
Dsg3 null skin. Scale bar, 20 µm. b Tables summarize the scores of
positive hair follicle staining for p53/active caspase-3 and p53/
p21WAF1/CIP1, respectively. Each hair follicle containing one or more
positively stained keratinocytes was scored positive
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surface receptors other than Dsgs16,17,42. Thus, the direct
link between Dsg3 and the p53 pathway is unclear. In this
study, we provide evidence of a potential link between Dsg3
and p53, indicating that disruption of Dsg3 by PV IgG may
cause p53 induction leading to caspase-3 activation. Our
in vitro study demonstrated that Dsg3 depletion causes
enhanced p53 with elevated expression of its targets
p21WAF1/CIP1, resulting in a reduction of PCNA and Cyclin
A coupled with elevated Bax/cleaved (activated) caspase-3.
We also showed that such responses were accelerated when
cells were exposed to stresses that trigger a p53 activation.
These in vitro findings were supported by an in vivo study
in Dsg3 null mice, as well as by the gain-of-function
studies that caused marked suppression of p53 and its
transcription activity. These findings collectively support
the hypothesis that Dsg3 dampens the stress response
pathway by negatively regulating p53. Notably, we showed
that this pathway is altered in ~50% PV patient samples
with enhanced p53 and caspase-3 that was not only found
in cells surrounding the blisters but also in pro-lesions
regions, indicating that activation of the p53 pathway
occurs early prior to the event of pemphigus acantholysis.
The apparent heterogeneity of p53 elevation in PV
patients could well reflect variations of clinical activities/
treatment status of the disease and/or be related to the
transient response of p53 to cellular stress. It is well-
known that drugs which caused DNA damage initially
induce high levels of p53, as well as p21WAF1/CIP1, but
these changes decline over time43. It is worth noting that
the specificity of p53 induction caused by antibody tar-
geting Dsg3 was verified by our in vitro studies with PV
sera (samples 17 cases) and a well-characterized specific
pathogenic monoclonal antibody, AK23 targeting the
Dsg3 adhesion site. Thus, our findings in PV may indicate
Fig. 5 Enhanced p53 and cleaved Caspase-3 expression is shown in clinical PV patient samples and also in keratinocyte cultures treated
with PV sera. p53 a and cleaved Caspase-3 b immunohistochemistry in oral mucous tissues from PV patients. Significantly enhanced p53 staining
was detected in 48% of patients (arrowheads indicate positive nuclear staining whereas arrows indicate predominant cytoplasmic staining),
compared to normal controls. Oral mucous cancer was used as positive control here. Asterisks indicate the areas of the blisters. Positive staining of
active caspase-3 was also detected in PV patients with the positive p53 staining in oral mucous tissues, especially in the basal and immediate
suprabasal layers of stratified squamous epithelium. The positive staining was also detected in cells located in sub-mucous connective tissue (right)
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a specific p53 induction associated with the PV IgG
induced Dsg3 disturbance since treatment of cells with
AK23 caused augmented p53 in a time and dose-
dependent manners. Taken together, these results sug-
gest that activation of the Dsg3-p53 pathway may con-
tribute, at least in part, to PV pathology36,39,40.
Activation of p53 also occurs in other chronic or
inflammatory conditions including LP26–28, psoriasis24,25
and Rheumatoid arthritis44 in which the role of Dsg3 has
not yet been defined. Thus, disruption of Dsg3 may be one
mechanism by which p53 can be activated in human skin
diseases. As p53 is a key factor in cell cycle control, dif-
ferentiation and apoptosis as well as a valuable biomarker
for prediction of malignant transformation, it is not sur-
prising to see the altered p53 expression in other condi-
tions although the molecular basis underlying the p53
activation may differ. Elevated p53 in psoriasis was
thought to be associated with cell proliferation24,25
whereas its detection in LP might be due to p53 gene
mutation26–28. Furthermore, an activated p53 pathway
can elicit pro-apoptotic/apoptotic events through multi-
ple mechanisms depending on the location and levels of
its expression. The cytoplasmic p53 can mediate apoptosis
by directly interacting with Bcl-2 family members45, while
nuclear p53 can bind to DNA and activate pro-apoptotic
gene expression, which ultimately contributes to disease
pathology.
The finding of increased caspase-3 in cells with Dsg3
knockdown may indicate early apoptosis, however, our
FACS analysis for Annexin V did not detect any evident
apoptosis in Dsg3 knockdown cells. A recent study has
highlighted that a transient, modulated activation of
caspase-3 is triggered by antibody-mediated Dsg3 dis-
ruption in PV, but this event is uncoupled from the
classical apoptotic pathways36. Nevertheless, active
caspase-3 in PV seems to be a consensus finding and
inhibition of caspase-3 has been shown to be effective in
preventing blister formation in both in vitro and in vivo
PV models. Thus, the anti-Dsg3 antibody mediated acti-
vation of p53 and its regulated target caspase-3 could well
be the key factor to cause PV acantholysis. In support of
this notion, activation of caspase-3 has been reported to
be a causative factor for the rapid disruption of tight
junctions in endothelial cells46. Furthermore, the staur-
osporine induces activation of caspase-3 is accompanied
by disturbance of adherens junctions accompanied by a
significant increase in cell permeability which can be
inhibited by pretreatment with caspase-3 specific
inhibitor47.
PV is a complex autoimmune disease with Dsg3 being a
central player in pemphigus acantholysis that likely is
triggered by a collection of signaling pathways, including
Src, p38 MAPK, EGFR, c-Myc, and Rho GTPases,
downstream of PV-IgG targeting Dsg3 disruption4,17. We
now report a potential involvement of abnormal p53
activation in PV caused by PV IgG targeting Dsg3 which
acts as an anti-stress protein in counterbalancing p53 in
the maintenance of normal epithelial homeostasis.
Materials and methods
Cell lines, animal and clinical patient oral mucosal samples
Various epithelial cell lines derived from skin and other
tissues were used in the study, i.e. NTERT immortalized
skin keratinocytes (wild-type p53: wtp53) maintained in
keratinocytes serum-free medium (KSFM) (17005042,
Thermo Scientific); T8 cutaneous squamous cell carci-
noma cell line with a frameshift mutation at amino acid
91 of TP53 resulting in a truncated protein and making it
essentially p53 null (gift from Prof. Catherine Harwood),
and they were cultured in complete keratinocyte growth
(see figure on previous page)
Fig. 6 Altered p53 expression and distribution were detected in keratinocyte cultures treated with PV sera and pathogenic antibody.
a Confocal microscopy of NTERTs treated with the PV sera, dual labeled for Dsg3 and p53. Cells were seeded at confluent densities in KGM for
overnight before being treated with PV sera (at 40% concentration in KGM) from a different cohort of PV patients (n= 17), for 24 h. Disruption or
depletion of Dsg3 at the plasma membrane accompanied with marked increases in p53 was observed in PV serum-treated cells that were abolished
by p53 knockdown, compared to controls exposed to sera of healthy individuals that displayed, predominantly, nuclear p53 signals. Of note, p53 also
showed distribution at the membrane where it colocalized with the fragmented Dsg3 (arrows in the inserts). Additional data for p53 knockdown was
shown in Supplementary material Fig. S5. The image magnification in PV serum-2 was doubled, relative to other panels, to highlight the disruption of
junctions and peripheral distribution of p53. b Scatter and whisker plots of Dsg3 and p53 cellular and subcellular expression (n= 16 for PV serum
samples, n= 6 for control samples). Student t-test and the Wilcoxon–Mann–Whitney Rank Test were used for statistically significant analysis here and
gave similar results. c The relative ratio of p53 nuclear versus cytoplasmic cellular distribution in controls and 16 PV sera treated NTERTs. d Treatment
of NTERTs with the pathogenic monoclonal antibody AK23 targeting Dsg3 N-terminus, caused p53 induction, in a time and dose-dependent manner
(n= 11 fields per condition, pooled from 2 independent experiments). For the dose-response experiment, cells were treated with AK23 for 6 h.
e Confocal images of cells with triple staining, treated in the presence and absence of AK23. Disruption of F-actin along with Dsg3 (arrowheads) was
readily detectable in cells exposed to AK23. Increase p53 expression was detected predominantly in the nucleus and also was observed at the plasma
membrane where it showed colocalization with Dsg3 and F-actin (arrows) in cells treated with AK23. The membrane distribution of p53 was not
detectable in control cells. The protein colocalization of the dotted line box is shown at the bottom. (*p < 0.05, **p < 0.01, ***p < 0.001). Scale bar,
10 µm. f Schematic model of Dsg3 in the suppression of p53 in keratinocyte response to stresses. Disruption of Dsg3 by RNAi or PV autoantibodies
evokes p53 induction
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medium KGM containing Dulbecco’s Modified Eagle
Medium (DMEM) (12–604F, Lonza):Ham’s 12 (11765054,
Thermo Scientific) in the ratio of 3:1 supplemented with
10% fetal calf serum (FCS) (Biosera), epidermal growth
factor (EGF) (13247-051, Invitrogen), Insulin human
solution (19278, Sigma), cholera toxin (C8052, Sigma),
and hydrocortisone (H4001, Sigma). MDCK (Madin
Darby canine kidney) cells (wt p53) are the simple epi-
thelial cell line, which is derived from canine kidney
tubule epithelium; A431 cell line (mutant p53-R273H) is
derived from vulva squamous cell carcinoma; A2780
ovarian cancer cell line (wt p53) and HCT116 colorectal
carcinoma cell line (wt p53). All these cell lines were
maintained in DMEM (12–604 F, Lonza) supplemented
with 10% FCS (Biosera, UK). Due to the low levels of
endogenous Dsg3 expression, these cell lines were used
for the gain-of-function studies by transduction of retro-
viral construct pBABE-hDsg3.myc along with the empty
vector control3,48 namely FL Dsg3 and Vect Ct cells,
respectively3. Cells were incubated at 37 °C in a humidi-
fied atmosphere of 95% air and 5% CO2. The medium was
changed on alternate days and cells were subjected to
subculture routinely once they reached to about 70–80%
confluence.
Mouse back skin samples from Dsg3 null (Dsg3−/−) and
heterozygous control littermates (Dsg3+/−) were
obtained, as described previously49. PV sera (anonymous,
17 cases) were received from our collaborator based in
First Department of Dermatovenerology, St. Anne’s
Faculty Hospital, Brno, Czech Republic, and oral tissue
samples of PV patients (25 PV cases and 10 normal
healthy tissue controls as well as 3 cancer patient samples)
were obtained from our collaborator in Guiyang Medical
University, China; all with informed patient consent and
ethical approval.
Antibodies
The following mouse (m) and rabbit (r) monoclonal/
polyclonal antibodies (Abs) were used: Dsg3 mAb against
the N-terminus (5H10) (sc-23912, Santa Cruz); Dsg3 rAb
against the C- terminus (H145) (sc-20116, Santa Cruz);
p53 mAb (DO-1) (ab1101, Abcam); p53 rAb (C-19) (sc-
1311-R, Santa Cruz); MDM2 rAb (EP16627) (ab178938,
Abcam); phospho MDM2 rAb (S166) (ab131355, Abcam);
p21WAF1/CIP1 rAb (C-19) (sc-397, Santa Cruz); Bax mAb
(sc-20067, Cell Signaling); Caspase3 rAb (clone C92-605,
RUO) (14C10, BD Biosciences); Caspase3 rAb (9662 S,
Cell Signaling); active Caspase3 rAb (ab49822, Abcam);
Desmoplakin rAb (sc-33555, Santa Cruz); Plakoglobin
mAb (PG51, Progen); Dsc2 rAb (610120, Progen); Dsg2
mAb (33-3D) was kindly received from Prof. David Gar-
rod; E-Cadherin mAb (HECD-1) (ab1416, Abcam); H-
432, rabbit Ab to Cyclin A (sc-751, Santa Cruz); PC10,
mouse Ab to PCNA (sc-56, Santa Cruz); Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) rAb (14c10, Cell
Signaling); HSC70 mAb (B6:sc-7298, Santa Cruz); β-actin
mAb (8H10D10, Cell Signaling); anti-53BP1 (05–726,
Upstate); anti-ATM (phospho S1981) (ab81292, Abcam);
anti-ATM (ab32420, Abcam); anti-CHK2 (phospho T68)
(ab32148, Abcam); anti-CHK2 (ab109413, Abcam). The
anti-ATM antibodies were validated on Western blots of a
range of normal and neoplastic oral keratinocytes lines
and ATM-deficient human epidermal keratinocytes from
an Altaxia Telangiectasia patient, the last of which showed
no ATM protein expression (K.Ng and E.K.Parkinson -
manuscript in preparation).
Treatments with ultraviolet (UV) B, drugs, and mechanical
stretching
The siRNA treated cells were seeded at confluence
densities in 6-well plates before irradiation of UVB
(10–30mj/cm2) using a CL-1000 Ultraviolet Crosslinker
(Ultra-Violet Products, CA) or treatment with actinomy-
cin D (Act-D, 5 nM) and mitomycin C (MMC, 5 ug/ml)
for 24 h, respectively. Protein lysates were extracted for
Western blotting analysis.
The regimen for the cyclic strain was adapted from a
previous publication50. Briefly, cells were plated at con-
fluent densities and grown for 1–2 days on collagen-
coated BioFlex 6-well plates (Flexcell® International
Corporation) prior to equiaxial cyclic stretching (20%
amplitude with 1 Hz, FX-5000 Tension System (Flexcell
International, Burlington, NC) for 4 h). Control cells were
seeded in the same plates without strain. Lysates were
extracted either immediately after strain or transferred to
the static state in an incubator and harvested later for the
indicated time points.
The details of siRNA/plasmid transfection/transduc-
tion, immunofluorescence, immunohistochemistry in PV
specimens, nuclear extraction, Western blotting, lucifer-
ase assay, FACS based Cell Viability-Caspase-3 assay and
RT-qPCR, etc. were described in Supplementary
Materials.
Statistical analysis
Statistical differences between control and test groups
were analyzed using unpaired, 2-tailed Student t-test in
most cases. For some experiments, the data were analyzed
by the Wilcoxon–Mann–Whitney Rank Test. Data are
presented as mean ± s.d. unless otherwise indicated. Two-
sided Fisher’s exact test was used for the comparison of
the positive hair follicle scoring in mice. Chi-Square sta-
tistic was used for obtaining the p values in the compar-
ison between PV patient samples and controls. P values of
less than 0.05 were considered statistically significant.
Experiments were repeated at least three times. The
microscopic images were acquired in >4–6 arbitrary fields
per sample. For Western blotting analysis, lysates were
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collected from three biologically independent replicates.
Wherever possible, the comparison between control and
test groups was normalized against the control and
expressed as a fold change relative to controls (set as 1).
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